Literature DB >> 16309565

Local administration of carbon monoxide inhibits neointima formation in balloon injured rat carotid arteries.

D A Tulis1, A N Keswani, K J Peyton, H Wang, A I Schafer, W Durante.   

Abstract

Recent studies indicate that systemic induction of heme oxygenase-1 (HO-1), which oxidatively degrades heme into iron, biliverdin, and carbon monoxide (CO), or adenoviral-mediated gene transfer of HO-1 inhibits neointima formation after experimental vascular injury. In the present study, we investigated whether the acute, local administration of the HO-1 product, CO, regulates the arterial remodeling response following injury. Immediately after balloon injury of rat carotid arteries, a saturated solution of CO or nitrogen (N2), or phosphate buffered saline (PBS) was incubated luminally within the injured vessels for 30 min. Two weeks after injury, arteries exposed to CO exhibited significantly reduced neointimal area, neointimal area/medial wall area ratio, neointimal thickness, and medial wall area compared to arteries exposed to N2 or PBS. Arteries exposed to CO also demonstrated significantly reduced DNA synthesis in the medial wall two days after injury as suggested by proliferating cell nuclear antigen immunostaining, and this was associated with a decrease in the protein expression of the G1 cyclins, cyclin E and A, and transforming growth factor-beta1. These results indicate that the acute, local delivery of CO blocks the pathophysiological remodeling response to vascular injury, and identifies CO as a potentially important therapeutic agent in the treatment of vasculoproliferative disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16309565      PMCID: PMC3658132     

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  29 in total

Review 1.  G1 phase progression: cycling on cue.

Authors:  C J Sherr
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

2.  Balloon injury does not induce heme oxygenase-1 expression, but administration of hemin inhibits neointimal formation in balloon-injured rat carotid artery.

Authors:  T Aizawa; N Ishizaka; J Taguchi; S Kimura; K Kurokawa; M Ohno
Journal:  Biochem Biophys Res Commun       Date:  1999-08-02       Impact factor: 3.575

3.  Protective roles of endogenous carbon monoxide in neointimal development elicited by arterial injury.

Authors:  Y Togane; T Morita; M Suematsu; Y Ishimura; J I Yamazaki; S Katayama
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-02       Impact factor: 4.733

4.  Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells.

Authors:  T Morita; S A Mitsialis; H Koike; Y Liu; S Kourembanas
Journal:  J Biol Chem       Date:  1997-12-26       Impact factor: 5.157

5.  Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide.

Authors:  T Morita; S Kourembanas
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

6.  CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule.

Authors:  Roberto Motterlini; Philip Sawle; Jehad Hammad; Sandip Bains; Roger Alberto; Roberta Foresti; Colin J Green
Journal:  FASEB J       Date:  2004-11-19       Impact factor: 5.191

7.  The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig.

Authors:  M J Post; C Borst; R E Kuntz
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

Review 8.  Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target?

Authors:  J W Currier; D P Faxon
Journal:  J Am Coll Cardiol       Date:  1995-02       Impact factor: 24.094

9.  Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model.

Authors:  Y G Wolf; L M Rasmussen; E Ruoslahti
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

10.  Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia.

Authors:  E G Nabel; L Shum; V J Pompili; Z Y Yang; H San; H B Shu; S Liptay; L Gold; D Gordon; R Derynck
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

View more
  14 in total

Review 1.  Novel therapies for cyclic GMP control of vascular smooth muscle growth.

Authors:  David A Tulis
Journal:  Am J Ther       Date:  2008 Nov-Dec       Impact factor: 2.688

Review 2.  Heme Oxygenases in Cardiovascular Health and Disease.

Authors:  Anita Ayer; Abolfazl Zarjou; Anupam Agarwal; Roland Stocker
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

Review 3.  Targeting heme oxygenase-1 in vascular disease.

Authors:  William Durante
Journal:  Curr Drug Targets       Date:  2010-12       Impact factor: 3.465

4.  Antigrowth properties of BAY 41-2272 in vascular smooth muscle cells.

Authors:  Natalia N Mendelev; Verietta S Williams; David A Tulis
Journal:  J Cardiovasc Pharmacol       Date:  2009-02       Impact factor: 3.105

5.  AMP-activated protein kinase inhibits vascular smooth muscle cell proliferation and migration and vascular remodeling following injury.

Authors:  Joshua D Stone; Avinash Narine; Patti R Shaver; Jonathan C Fox; Jackson R Vuncannon; David A Tulis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-11-30       Impact factor: 4.733

6.  HO-1 and CO decrease platelet-derived growth factor-induced vascular smooth muscle cell migration via inhibition of Nox1.

Authors:  Andres I Rodriguez; Archana Gangopadhyay; Eric E Kelley; Patrick J Pagano; Brian S Zuckerbraun; Philip M Bauer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-29       Impact factor: 8.311

7.  Activation of vascular endothelial nitric oxide synthase and heme oxygenase-1 expression by electrophilic nitro-fatty acids.

Authors:  Nicholas K H Khoo; Volker Rudolph; Marsha P Cole; Franca Golin-Bisello; Francisco J Schopfer; Steven R Woodcock; Carlos Batthyany; Bruce A Freeman
Journal:  Free Radic Biol Med       Date:  2009-10-24       Impact factor: 7.376

8.  The cyclic GMP modulators YC-1 and zaprinast reduce vessel remodeling through antiproliferative and proapoptotic effects.

Authors:  Amit N Keswani; Kelly J Peyton; William Durante; Andrew I Schafer; David A Tulis
Journal:  J Cardiovasc Pharmacol Ther       Date:  2009-04-02       Impact factor: 2.457

9.  Nitro-fatty acid inhibition of neointima formation after endoluminal vessel injury.

Authors:  Marsha P Cole; Tanja K Rudolph; Nicholas K H Khoo; Uche N Motanya; Franca Golin-Bisello; Jeffrey W Wertz; Francisco J Schopfer; Volker Rudolph; Steven R Woodcock; Subhashini Bolisetty; Muhammad S Ali; Jifeng Zhang; Y Eugene Chen; Anupam Agarwal; Bruce A Freeman; Philip M Bauer
Journal:  Circ Res       Date:  2009-09-24       Impact factor: 17.367

Review 10.  New insights into intracellular locations and functions of heme oxygenase-1.

Authors:  Louise L Dunn; Robyn G Midwinter; Jun Ni; Hafizah A Hamid; Christopher R Parish; Roland Stocker
Journal:  Antioxid Redox Signal       Date:  2014-02-28       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.